Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mach7 Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
Q+A: Mach 7 CEO Mike Lampron on a barnstorming year and why AI isn’t the easy win it looks like
Experts
MoneyTalks: Wilsons initiates coverage on Mach7 with lofty price target, Goldman rates Judo Cap a buy
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but Dimerix up 150% on drug licensing deal
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as big names ‘trading at very attractive fundamentals’
Health & Biotech
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
Health & Biotech
ScoPo’s Powerplays: CSL leads ASX health stocks down is reporting season; ‘we weren’t expecting that’
Health & Biotech
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer
Health & Biotech
ASX Health Stocks: Starpharma jumps 10pc on study results; Mach7 announces $3.7m deal
News
Market Highlights: Earnings weigh on Wall Street; VIX falls below 14, signals ‘new bull market’
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall in first week of FY23 as Mach 7 scores biggest deal in its history
Health & Biotech
Which ASX health companies are making strides in world’s largest healthcare market?
Health & Biotech
Check Up: Diet Coke put on notice as WHO labels artificial sweetener aspartame ‘possibly carcinogenic’
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results
Health & Biotech
Mach 7 positions for enterprise imaging uptake solving tomorrow’s problems with today’s software
Health & Biotech
